Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Stevanato Group S.p.A. Ordinary Shares (NY:STVN)

21.80 +0.55 (+2.59%)
Official Closing Price Updated: 7:00 PM EDT, May 7, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Stevanato Group S.p.A. Ordinary Shares

< Previous 1 2 3 Next >
Stevanato Group to Report First Quarter 2025 Financial Results on May 8, 2025
From Stevanato Group
Via Business Wire
Stevanato Group to Participate in the KeyBanc Capital Markets Virtual Healthcare Forum
From Stevanato Group
Via Business Wire
Stevanato Group Reports Record Revenue of €1,104 Million for Fiscal Year 2024
From Stevanato Group S.p.A.
Via Business Wire
Stevanato Group to Report Fourth Quarter and Fiscal Year 2024 Financial Results on March 6, 2025
From Stevanato Group
Via Business Wire
Stevanato Group to Present at Upcoming Investor Conference
From Stevanato Group
Via Business Wire
Stevanato Group to Present at Upcoming Investor Conferences
From Stevanato Group
Via Business Wire
Stevanato Group Reports Financial Results for the Third Quarter of 2024
From Stevanato Group
Via Business Wire
Stevanato Group to Report Third Quarter 2024 Financial Results on November 5, 2024
From Stevanato Group S.p.A.
Via Business Wire
Stevanato Group Will Introduce Its Large-Volume Vertiva® 10mL On-Body Delivery System Platform for Injectable Therapies at CPHI Milan
From Stevanato Group
Via Business Wire
Stevanato Group, Gerresheimer and SCHOTT Pharma, Announce Strategic Industry “Alliance for RTU”
From Stevanato Group
Via Business Wire
Stevanato Group to Present at Upcoming Investor Conferences
From Stevanato Group S.p.A.
Via Business Wire
Stevanato Group Reports Financial Results for the Second Quarter of 2024
From Stevanato Group S.p.A.
Via Business Wire
Stevanato Group to Report Second Quarter 2024 Financial Results on August 6, 2024
From Stevanato Group S.p.A.
Via Business Wire
Stevanato Group Unveils New Plant in Cisterna di Latina for the Production of Pre-Sterilized EZ-fill® Syringes and Cartridges
From Stevanato Group
Via Business Wire
Stevanato Group Appoints Franco Stevanato Chief Executive Officer, Succeeding Franco Moro
From Stevanato Group S.p.A.
Via Business Wire
Stevanato Group Announces Results of Annual General Meeting
From Stevanato Group S.p.A.
Via Business Wire
Stevanato Group to Present at Upcoming Investor Conferences
From Stevanato Group S.p.A.
Via Business Wire
Stevanato Group Reports Financial Results for the First Quarter of 2024
From Stevanato Group S.p.A.
Via Business Wire
Stevanato Group to Present at the Bank of America Securities Healthcare Conference
From Stevanato Group S.p.A.
Via Business Wire
Stevanato Group to Report First Quarter 2024 Financial Results on May 9, 2024
From Stevanato Group S.p.A.
Via Business Wire
Stevanato Group appoints Ugo Gay as Chief Operations Officer
From Stevanato Group S.p.A.
Via Business Wire
Stevanato Group Announces Closing of Upsized Public Offering of Ordinary Shares and Exercise in Full of the Underwriters’ Option to Purchase Additional Ordinary Shares
From Stevanato Group S.p.A.
Via Business Wire
Stevanato Group Announces Pricing of Upsized Public Offering of Ordinary Shares
From Stevanato Group S.p.A.
Via Business Wire
Stevanato Group Announces Public Offering of Ordinary Shares
From Stevanato Group S.p.A.
Via Business Wire
Stevanato Group to Present at the KeyBanc Capital Markets Virtual Life Sciences & MedTech Investor Forum
From Stevanato Group S.p.A.
Via Business Wire
Stevanato Group Delivers Double-Digit Revenue Growth in Fiscal Year 2023
From Stevanato Group S.p.A.
Via Business Wire
Stevanato Group to Report Fourth Quarter and Year End 2023 Financial Results on March 7, 2024
From Stevanato Group S.p.A.
Via Business Wire
Stevanato Group Launches EZ-fill® Kit and Laboratory Fill and Finish Service to Support Small Batch Drug Development and Commercialization
From Stevanato Group S.p.A.
Via Business Wire
Stevanato Group to Present at the 42nd Annual J.P. Morgan Healthcare Conference
From Stevanato Group S.p.A.
Via Business Wire
Stevanato Group's Mavis™ Combi Visual Inspection Machine Selected as Pharma Innovation Award Winner by Pharma Manufacturing
From Stevanato Group
Via Business Wire
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.